IQVIA™ Real-World Insights Bibliography

Real-world treatment and health care resource use among severe asthma patients in Japan
Author(s): Yasuo To 1, Yurie Taguchi 2, Tatsuya Shimazaki 2, Kazuhiko Arima 2, Eric Yu 3, Sven Demiya 3, Takashi Iwanaga 4 (rwesheorj 3)
Affiliations(s): 1) Department of Pulmonary Medicine, International University of Health and Welfare, School of Medicine, 1-4-3 Mita, Minato-ku, Tokyo 108-8329, Japan 2) Sanofi K.K., 3-20-2 Nishi Shinjuku, Shinjuku-ku, Tokyo 163-1488, Japan 3) IQVIA Solutions Japan K.K., Keikyu Dai-7 Building 4-10-8, Takanawa Minato-ku, Tokyo 108-0074, Japan 4) Kindai University, 377-2 Ohno Higashi, Osakasayama City, Osaka 589-8511, Japan
Publication(s):  Respiratory Investigation
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Clinical practice,
2021
  L:
A:
English
Database Study,
  Add to report
 
 
The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results
Author(s): Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8
Affiliations(s): 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la Santé, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands
Publication(s):  European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020
Document Type(s): Poster,
Countries: Belgium, France, Germany, Italy, UK,
C:
Y:
Clinical practice, Public Health,
2020
  L:
A:
English
Population Based Study, Public Health, Retrospective database analysis,
  Add to report
 
 
Interventional or Non-Interventional? Analyzing the Differences Between Clinical Studies Using Medicines in the European Union
Author(s): Tiago Silva, MSc; Alexandra Parnell, MSc; Christopher Bamford, PhD; Catherine Paulen, PharmD; Simona Francisconi, MSc; Jaclyn Bosco, PhD, MPH; Louise Parmenter, PhD, MSc
Affiliations(s): 
Publication(s):  Clinical Researcher February 11, 2020
Clinical Trial Regulation (EU) No. 536/2014 (REG 536/2014
Document Type(s): Article, Online article,
Countries: Europe,
Click here for the abstract
C:
Y:
Clinical practice,
2020
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
Patient characteristics and treatment patterns in multiple myeloma by treatment administration route and disease status: EASEMENT observational study
Author(s): Rabin N1, Kotb R2, Zomas A3, Gonzalez F3, Fernandez-Nistal A3, D?Ambrosio R3, Bent-Ennakhil N3, Roset M4, Annibali O5
Affiliations(s): 1 University College Hospital, London, UK 2 Cancer Care Manitoba, Canada 3 Takeda Pharmaceuticals International AG, Switzerland 4 IQVIA, Barcelona, Spain 5 Università Campus Bio-Medico di Roma, Italy
Publication(s):  IMW, Boston, US, 12-15 September 2019
Document Type(s): Poster,
Countries: Canada, Italy, UK,
Click here for the abstract
C:
Y:
Clinical practice, Hematology,
2019
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY
Author(s): Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US
Publication(s):  EUROGIN, Monaco, France, 4-7 December 2019
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Spain, UK, USA,
Click here for the abstract
C:
Y:
Clinical practice, Infectious disease, Methodology,
2019
  L:
A:
English
Epidemiological study, Observational study, Population Based Study,
  Add to report
 
 
Assessing and modeling organizational impact of tilmanocept in performing sentinel lymph node biopsy in France
Author(s): Clément Le Dissez1, Pascal Paubel2, Frédéric Courbon3, Rémy Herve4, Mark Rance5, Marie-Aude Courteille6
Affiliations(s): 1IQVIA Opération France, Paris, La Défense ; 2Inserm UMR S 1145, Institut Droit et Santé, faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, 4 avenue de l’observatoire, 75006 Paris, France ; 3 Department of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France ; 4 Department of Pharmacy, Institute of Cancerology Gustave Roussy, University of Paris-Sud, Villejuif, France ; 5Norgine, Corporate ; 6Norgine, France
Publication(s): 
Document Type(s): Poster,
Countries: France,
C:
Y:
Clinical practice, Health economics, Oncology,
2018
  L:
A:
English
Budget impact, Literature Review, Public Health,
  Add to report
 
 
Available resources for the management of chronic obstructive pulmonary disease exacerbations in Spain
Author(s): Soler-Cataluña JJ1, Fernández Villar A2, Piñera Salmerón PL3, Román-Rodríguez M4, Huerta Hernández A5, Roset Gamisans M6
Affiliations(s): 1 Servicio de Neumología, Hospital de Arnau de Vilanova-Lliria, Valencia, España. 2 Servicio de Neumología, Hospital Álvaro Cunqueiro. Instituto de Investigación Biomédica Galicia Sur, Vigo (Pontevedra), España. 3 Servicio de Urgencias, Hospital General Universitario Reina Sofía, Murcia, España. 4 Médico de familia, Centro de Salud Son Pisà, Islas Baleares, Mallorca, España. 5 Departamento de Evaluación de Medicamentos, GlaxoSmithKline, Tres Cantos, Madrid, España. 6 Health Economics and Outcomes Research, IQVIA, Barcelona, España.
Publication(s):  Semergen. 2018 Oct;44(7):449-457
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Clinical practice,
2018
  L:
A:
Spanish
Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Observational study,
  Add to report
 
 
Antibiotic Therapy in Children with Otitis Media in ENT Specialists and Pediatricians
Author(s): Kostev K, Dombrowski S, Seidel DU
Affiliations(s): IQVIA, Frankfurt am Main, Germany Städtisches Klinikum Solingen, Solingen, Germany
Publication(s): 
Document Type(s): Abstract,
Countries: 
C:
Y:
Clinical practice, Pediatrics,
2018
  L:
A:
English
  Add to report
 
 
5-ASA Prescription Trends over Time in Inflammatory Bowel Disease 1996 to 2015-A UK Population-Based Study
Author(s): Jaraith, V, S Hokkanen, L Guizzetti, N Boxall, S Campbell-Hill, and H Patel
Affiliations(s): Western University, Department of Medicine, London, Ontario, Canada, Robarts Clinical Trials Inc., London, Ontario, Canada, IQVIA, London, UK,
Publication(s):  Journal of Crohn, no. Supplement 1 (February): S309?10
Document Type(s): Abstract,
Countries: UK,
Click here for the abstract
C:
Y:
Clinical practice, Drug Utlization Study, Gastrointestinal disorders,
2018
  L:
A:
English
Epidemiological study, Retrospective cohort analysis,
  Add to report
 
 
Real-world treatment patterns and outcomes for mNSCLC patients receiving second- and third-line therapy in Germany
Author(s): Yu N1, Rivera I2, Hipp J3, Zou M4, Pillai N4, Hammerschmidt S5
Affiliations(s): 1 Roche Products Ltd, Welwyn, UK 2 F. Hoffmann-La Roche, Basel, Switzerland 3 Roche Pharma AG, Grenzach-Wyhlen, Germany 4 QuintilesIMS, Basel, Switzerland 5 Klinikum Chemnitz gGmbH, Chemnitz, Germany
Publication(s): 
Document Type(s): Poster,
Countries: Germany,
Click here for the abstract
C:
Y:
Clinical practice, Health status & patient reported outcomes, Oncology,
2017
  L:
A:
English
clinical setting: Secondary care, Patient questionnaire, Quality of life,
  Add to report
 
 
 1 of 5 Next Page Last Page